Nanobiomaterials for drug delivery and theranostics

Show simple item record

dc.contributor.author Bajpai, Aman
dc.contributor.author Shinde, Sopan
dc.contributor.author Basu, Sudipta
dc.coverage.spatial Amsterdam
dc.date.accessioned 2022-05-06T15:36:44Z
dc.date.available 2022-05-06T15:36:44Z
dc.date.issued 2022-01
dc.identifier.citation Bajpai, Aman; Shinde, Sopan and Basu, Sudipta, “Nanobiomaterials for drug delivery and theranostics”, in Nanotechnology in medicine and biology, DOI: 10.1016/B978-0-12-819469-0.00002-2, Amsterdam: Elsevier, pp. 25-56, Jan. 2022, ISBN: 9780128194690. en_US
dc.identifier.isbn 9780128194690
dc.identifier.uri http://dx.doi.org/10.1016/B978-0-12-819469-0.00002-2
dc.identifier.uri https://repository.iitgn.ac.in/handle/123456789/7697
dc.description.abstract Recent advances have shown that nanotechnology research is no longer restricted to drug delivery; instead, it has provided a new form of therapeutic strategy through which the personalized form of cancer treatment is possible. This chapter highlights the drug delivery and theranostic application of selective self-assembled and synthetic nanovectors engineered from organic and inorganic materials for cancer treatment. The chapter starts with a brief introduction emphasizing the role of nanomaterials in revolutionizing therapy and diagnosis (theranostics) of different life-threatening diseases including cancer, infectious, cardiovascular, autoimmune, and neurodegenerative diseases in the past two decades. It then discusses the design parameters of nanovectors used for drug delivery and theranostic applications followed by their targeting mechanisms and their off-target toxicities. An expanded discussion of the advancements in the different types of nanovectors and their structural features is included to relate it with the therapeutic efficacy of the drug used for cancer management.
dc.description.statementofresponsibility by Aman Bajpai, Sopan Shinde and Sudipta Basu
dc.format.extent pp. 25-56
dc.language.iso en_US en_US
dc.publisher Elsevier en_US
dc.subject Drug delivery en_US
dc.subject Theranostics en_US
dc.subject Carrier en_US
dc.subject Cancer en_US
dc.subject Targeted delivery en_US
dc.subject Active targeting en_US
dc.subject Passive targeting en_US
dc.subject Toxicity en_US
dc.subject PEGylation en_US
dc.title Nanobiomaterials for drug delivery and theranostics en_US
dc.type Book Chapter en_US
dc.relation.journal Nanotechnology in medicine and biology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account